Navigation Links
Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
Date:1/17/2013

ronic HCV, accounting for 15,000 deaths in the United States in 2007.

About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

*Sustained virologic response (SVR) 12 and 24 weeks following treatment completion


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
2. Boehringer Ingelheim Announces Equine Research Awards
3. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
4. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
5. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
6. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
7. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
8. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
9. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
10. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
11. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014  Tasly Pharmaceuticals, Inc., the world,s leader ... today the launch of Deepure. Deepure ... men and women concerned with supporting their overall ... age while helping keep their health care cost ... herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and ...
(Date:9/30/2014)... , Sept. 30, 2014 STUDY ... this study is to provide an overview of ... market for protein drugs/therapeutics. The key objective is ... of protein drugs as an important tool in ... explores present and future strategies within the protein ...
(Date:9/30/2014)... , Sept. 30, 2014 Aileron Therapeutics, ... Summary Global Markets Direct,s, ,Aileron Therapeutics, Inc. ... overview of the Aileron Therapeutics, Inc.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
Breaking Medicine Technology:Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... Futuremed Healthcare Products Corporation (" Futuremed ") (TSX: FMD) ... a wholly-owned subsidiary of Cardinal Health, Inc. (NYSE: ... its offer to acquire all of the outstanding common shares ... Common Share in cash (the " Offer ") and mailed ...
... /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ... Fiscal Year 2012. First quarter ... September 30 , 2011 financial highlights ...
Cached Medicine Technology:Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 2Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 3Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 4TPI Reports First Quarter Fiscal Year 2012 Financial Results 2TPI Reports First Quarter Fiscal Year 2012 Financial Results 3TPI Reports First Quarter Fiscal Year 2012 Financial Results 4TPI Reports First Quarter Fiscal Year 2012 Financial Results 5TPI Reports First Quarter Fiscal Year 2012 Financial Results 6TPI Reports First Quarter Fiscal Year 2012 Financial Results 7TPI Reports First Quarter Fiscal Year 2012 Financial Results 8TPI Reports First Quarter Fiscal Year 2012 Financial Results 9TPI Reports First Quarter Fiscal Year 2012 Financial Results 10TPI Reports First Quarter Fiscal Year 2012 Financial Results 11
(Date:10/1/2014)... (PRWEB) October 01, 2014 Join the more ... Eating Disorder Treatment Center’s first ever charity golf tournament to ... people with eating disorders who cannot afford treatment. The tournament ... Club in Eureka, Mo. , The day-long event starts ... A reception and award dinner will begin at 5 p.m. ...
(Date:10/1/2014)... Innovations announces the upcoming airing of Innovations ... October 20, 2014 at 7:30 a.m. EST/PT via Discovery ... the scenes to learn about Break the Cycle’s comprehensive ... practical help and information Break the Cycle provides to ... of abuse, how to navigate the legal system, and ...
(Date:10/1/2014)... 01, 2014 Scientists at the University ... that target immune system proteins has the power to ... posted details of the new study on their website. ... , Researchers in the UWA School of Pathology and ... to mice with mesothelioma with promising results. , ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 October is ... awareness and early detection plans while raising money for ... support Breast Cancer Awareness Month in the effort ... wants to promote the importance of having access to ... water may be linked to certain forms of cancer. ...
(Date:10/1/2014)... Two bicyclists began a journey on ... country in an effort to raise funds and awareness ... cyclists, a father-daughter team, plan to bike more than ... and finishing in Key West Florida. Funds raised ... a national nonprofit organization that assists post-9/11 service members, ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2
... SERIOUS MOISTURIZERMINNEAPOLIS, May 11 Upsher-Smith has revamped its AmLactin(R) ... labels. Just in time for summer, dry skin sufferers can ... to use packaging, any of the AmLactin(R) products ... design of the new bottles and tubes is dually colored ...
... key: making it simpler.MCLEAN, Va., May 11 ... the Department of Health and Human Services, to adopt ... electronically (be interoperable). Qualified Electronic Health Records are ... be interoperable under the new law. Sec. Sebelius ...
... a 501-C3 nonprofit organization, is announcing its first national ... Sojourner-Douglass College , located in Baltimore Maryland. The telethon ... 6pm, and will raise money to assist victims of ... supplements.To view the Multimedia News Release, go to: ...
... May 11 Empty offices and deserted restaurants are,a ... warns the,Economist Intelligence Unit. The public has been suffering ... As a result, the threat,of this flu outbreak has ... could surge later in the year with dire results. ...
... 11 Africa,s healthcare ... the global economic slowdown. Pressures from the global ... constrained healthcare resources.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )"Countries that ... are largely driven by commodity exports," says Frost ...
... sanitizers and hand wipes are alcohol based. Over-use of hand sanitizers ... causing cracks that open a direct pathway to the human bloodstream. ... , ... Erath, Louisiana (PRWEB) May 11, 2009 -- ...
Cached Medicine News:Health News:AmLactin(R) Family of Moisturizers Has a New Look 2Health News:Patient Command Tells Sec. Sebelius That Existing Technology Can Make Electronic Health Records Interoperable 2Health News:Not All Gloomy for African Healthcare Markets: Frost & Sullivan Finds Potential Despite the Recession 2Health News:Not All Gloomy for African Healthcare Markets: Frost & Sullivan Finds Potential Despite the Recession 3Health News:Q-Based Healthcare Warns: Hand Sanitizers Increase Risk of Swine Flu Exposure 2Health News:Q-Based Healthcare Warns: Hand Sanitizers Increase Risk of Swine Flu Exposure 3
Rees bayonet forceps, standard, 5-1/2", TC....
... Channel Implants, designed to accept ... surgeon with an excellent reconstructive ... and floor blowout defects. Each ... placement of one or more ...
Medpor Complete Orbit are designed to replace non load bearing bony structures in the orbital area....
... Medpor Inferior Orbital Rim implant can provide ... is designed to be trimmed to meet ... small flange allows it to rest on ... floor. This flange allows easier positioning of ...
Medicine Products: